Printer Friendly

ALLERGAN RECEIVES FDA APPROVAL FOR ONE-STEP HYDROGEN PEROXIDE CONTACT LENS DISINFECTION SYSTEM

 ALLERGAN RECEIVES FDA APPROVAL FOR ONE-STEP
 HYDROGEN PEROXIDE CONTACT LENS DISINFECTION SYSTEM
 IRVINE, Calif., March 4 /PRNewswire/ -- Allergan Inc. (NYSE: AGN) has received approval from the U.S. Food and Drug Administration (FDA) to market UltraCare Disinfectant/Neutralizer.
 Allergan developed UltraCare, a simplified one-step hydrogen peroxide contact lens disinfection method, in response to an increasing demand for easy-to-use systems and patient convenience.
 Allergan Inc., headquartered in Irvine, is a global provider of specialty therapeutic products, and is now expanding beyond skin care and its leadership position in eye care.
 -0- 3/4/92
 /CONTACT: Shel Holtz (media), 714-752-4387 or (home) 818-366-5296; or Jeff D'Eliscu (investors), 714-752-4636 or (home) 714-675-9475, both of Allergan/
 (AGN) CO: Allergan Inc. ST: California IN: MTC SU:


KJ -- LA036 -- 5125 03/04/92 16:37 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 4, 1992
Words:130
Previous Article:DAYTON HUDSON, TARGET, MERVYN'S RECEIVE HONORS FOR THE FAMILY-TO-FAMILY CHILD CARE INITIATIVE
Next Article:25-PERCENT DUTY ON MULTI-PURPOSE VEHICLES: A HUGE TAX INCREASE ON THE MIDDLE CLASS
Topics:


Related Articles
TEETH WHITENERS DO NOT HARM TEETH, SAYS INDUSTRY COALITION WHICH OPPOSES FDA POSITION
ALLERGAN REPORTS FOURTH QUARTER AND 1991 YEAR END OPERATING RESULTS FOURTH QUARTER EVENTS SUPPORT STRATEGIC DIRECTION FOR THE 1990s
ALLERGAN REPORTS SECOND QUARTER OPERATING RESULTS; EARNINGS PER SHARE FROM CONTINUING OPERATIONS INCREASE 31 PERCENT
Cygnus' GlucoWatch(R) Monitor to Be Reviewed by FDA Panel December 6, 1999.
ALLERGAN'S BOTOX GETS FDA APPROVAL FOR CERVICAL DYSTONIA.
Allergan's COMPLETE Multi-Purpose Solution Receives No-Rub Approval; Convenient New Packaging Hits the Shelves.
ALLERGAN REPORTS FIRST QTR. 8.8% INCREASE IN WORLDWIDE SALES.
Cyberonics Receives FDA Real-Time Review Approval For Next Generation Programming Software; Software approval is first step towards approval of new...
Cyberonics Announces FDA Approval of Hydrogen Peroxide Sterilization Process.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters